A phase II study of intermittent Gleevec [imatinib] and weekly paclitaxel in patients aged 70 or older with advanced non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2006
At a glance
- Drugs Imatinib (Primary) ; Tamoxifen
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 27 Jun 2006 New trial record.